Gover Justin D. — SEC Form 4 filings
SEC reporting owner CIK 1754129. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-05 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | Director | 3 | — | — | 7 |
| Design Therapeutics, Inc. (DSGN) | Director | 3 | — | — | 4 |
| COMPASS Pathways plc (CMPS) | Director | 2 | — | — | 2 |
Form 4 filings — Gover Justin D.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Design Therapeutics, Inc. (DSGN) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 2,645 · Option exercise (M): 2,645 (derivative) @ $0 · Grant/award (A): 10,507 (derivative) @ $0 · Grant/award (A): 1,593 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Design Therapeutics, Inc. (DSGN) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Design Therapeutics, Inc. (DSGN) | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,833 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 17,012 (derivative) @ $0 · Grant/award (A): 2,645 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 15,542 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1754129 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →